72235-55-3 Usage
Uses
Used in Pharmaceutical Industry:
3-Chloro-2-fluorobenzylamine is used as a synthetic intermediate for the development of pharmaceuticals, contributing to the creation of new drugs and enhancing the therapeutic options available in the medical field.
Used in Agrochemical Industry:
In the agrochemical sector, 3-Chloro-2-fluorobenzylamine serves as a key intermediate in the synthesis of agrochemicals, playing a crucial role in the production of pesticides and other agricultural chemicals that protect crops and enhance agricultural productivity.
Used in Organic Compounds Production:
3-Chloro-2-fluorobenzylamine is utilized as a building block in the production of various organic compounds, including dyes and pigments, which are essential for coloring textiles, plastics, and other materials. Additionally, it contributes to the synthesis of polymers, which have a wide range of applications in the manufacturing of plastics, resins, and other materials.
Used in Medicinal Chemistry Research:
3-Chloro-2-fluorobenzylamine holds potential in medicinal chemistry, as it is being investigated for its possible applications in drug development. Its unique structure and properties make it a promising candidate for the discovery of new therapeutic agents and the advancement of medical science.
Check Digit Verification of cas no
The CAS Registry Mumber 72235-55-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,2,2,3 and 5 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 72235-55:
(7*7)+(6*2)+(5*2)+(4*3)+(3*5)+(2*5)+(1*5)=113
113 % 10 = 3
So 72235-55-3 is a valid CAS Registry Number.
InChI:InChI=1/C7H7ClFN/c8-6-3-1-2-5(4-10)7(6)9/h1-3H,4,10H2
72235-55-3Relevant academic research and scientific papers
NOVEL METHODS AND COMPOSITIONS FOR ALLEVIATING PAIN
-
Page 62, (2010/02/04)
The present invention provides a method for the long-term relief of chronic pain in a subject by activating in the subject an analgesic α-adrenergic receptor in the absence of α-2A receptor activation over a period of at least three days, such that relief of chronic pain is maintained in the absence of continued activation of said receptor. The analgesic α-adrenergic receptor can be, for example, the α-2B receptor.